blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3810139

EP3810139 - TRICYCLIC PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  31.05.2024
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  26.03.2021
FormerThe international publication has been made
Status updated on  27.12.2019
Formerunknown
Status updated on  25.06.2019
Most recent event   Tooltip29.06.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
HepaRegeniX GmbH
Eisenbahnstr. 63
72072 Tübingen / DE
[2021/17]
Inventor(s)01 / JUCHUM, Michael
Heinrich-von-Brentano-Straße 14
64625 Bensheim / DE
02 / SELIG, Roland
Allacher Str. 311
80999 München / DE
03 / LAUFER, Stefan
Otto-Erbe-Weg 86
72070 Tübingen / DE
04 / ALBRECHT, Wolfgang
Alfred-Mendler-Weg 25/1
89075 Ulm / DE
 [2021/17]
Representative(s)Meissner Bolte Partnerschaft mbB
Patentanwälte Rechtsanwälte
Postfach 86 06 24
81633 München / DE
[N/P]
Former [2021/17]Reitstötter Kinzebach
Patentanwälte
Sternwartstrasse 4
81679 München / DE
Application number, filing date19730377.918.06.2019
[2021/17]
WO2019EP65995
Priority number, dateEP2018017903521.06.2018         Original published format: EP 18179035
[2021/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019243315
Date:26.12.2019
Language:EN
[2019/52]
Type: A1 Application with search report 
No.:EP3810139
Date:28.04.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 26.12.2019 takes the place of the publication of the European patent application.
[2021/17]
Search report(s)International search report - published on:EP26.12.2019
ClassificationIPC:A61K31/4745, A61P31/20
[2021/17]
CPC:
A61K31/4745 (EP); C07D471/04 (US); A61P31/20 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/17]
TitleGerman:TRICYCLISCHE PROTEINKINASEINHIBITOREN ZUR FÖRDERUNG DER LEBERREGENERATION ODER ZUR VERMINDERUNG ODER VERHINDERUNG DES HEPATOZYTENTODES[2021/17]
English:TRICYCLIC PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH[2021/17]
French:INHIBITEURS DE PROTÉINE KINASE TRICYCLIQUES POUR FAVORISER LA RÉGÉNÉRATION DU FOIE OU RÉDUIRE OU PRÉVENIR LA MORT DES HÉPATOCYTES[2021/17]
Entry into regional phase16.12.2020National basic fee paid 
16.12.2020Designation fee(s) paid 
16.12.2020Examination fee paid 
Examination procedure16.12.2020Examination requested  [2021/17]
16.12.2020Date on which the examining division has become responsible
21.12.2020Observations by third parties
03.08.2021Amendment by applicant (claims and/or description)
04.06.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
29.06.2021Renewal fee patent year 03
29.06.2022Renewal fee patent year 04
28.06.2023Renewal fee patent year 05
28.06.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US6514981  (TANG PENG CHO [US], et al);
 [A]FR2876377  (UNIV CLAUDE BERNARD LYON [FR], et al);
 [A]EP2161271  (UNIV MILANO BICOCCA [IT], et al);
by applicantWO2007002433
 WO2007002325
 WO2010002325
 WO2010111527
 WO2011079133
 WO2012109075
 WO2012136859
 WO2014194127
 WO2016000827
 WO2016112305
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.